Single-cell proteomic analysis using mass cytometry shows that CD8+ cells clustered into unique subsets based on surface marker expression that were similar across patients for each sample of origin, including PBMCs, RCC tumor, and adjacent kidney tissue. This evidence concerns the gene CD8A and neoplasm.